Eosinophil Granule Proteins Activate Human Heart Mast Cells

Journal of Immunology

Volumn 157, Issue 3, 1996, Pages 1219-1225

  Patella, Vincenzo ^a   De Crescenzo, Gennaro ^a   Marinò, Isabella ^a   Genovese, Arturo ^a   Adt, Monika ^b   Gleich, Gerald J ^c   Marone, Gianni ^a,d  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; CHYMASE; CHYMASE 2; EOSINOPHIL GRANULE PROTEIN; EOSINOPHIL PEROXIDASE; EOSINOPHIL PROTEIN X; NEUROTOXIN; PEROXIDASE; PLASMA PROTEIN; PROSTAGLANDIN D2; RIBONUCLEASE; SERINE PROTEINASE; TRYPTASE;

ARTICLE; BIOSYNTHESIS; CYTOLOGY; EOSINOPHIL; HEART MUSCLE; HISTAMINE RELEASE; HUMAN; IMMUNOLOGY; KINETICS; MAST CELL; METABOLISM; PHYSIOLOGY;

BLOOD PROTEINS; CHYMASES; EOSINOPHIL GRANULE PROTEINS; EOSINOPHIL PEROXIDASE; EOSINOPHIL-DERIVED NEUROTOXIN; EOSINOPHILS; HISTAMINE RELEASE; HUMANS; INFLAMMATION MEDIATORS; KINETICS; MAST CELLS; MYOCARDIUM; NEUROTOXINS; PEROXIDASES; PROSTAGLANDIN D2; RIBONUCLEASES; SERINE ENDOPEPTIDASES; TRYPTASES;

EID: 0030210312     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (67)

1. Löffler, W. 1936. Endocarditis parietalis fibroblastica unit bluteosinophilie, ein eigenartiges krankheitsbild. Schweiz Med. Wochenschr. 66:817.
2. Brink, A. J., and H. W. Weber. 1963. Fibroplastic parietal endocarditis with eosinophilia: Löffler endocarditis. Am. J. Med. 34:52.
3. Chusid, M. J., D. C. Dale, and S. M. Wolff. 1975. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine 54:1.
4. Parrillo, J. E., J. S. Borer, W. L. Henry, S. M. Wolff, and A. S. Fauci. 1979. The cardiovascular manifestations of the hypereosinophilic syndrome: prospective study of 26 patients, with review of the literature. Am. J. Med. 67:572.
5. Harley, J. B., C. L. McIntosh, J. J. W. Kirklin, B. J. Maron, J. Gottdiener, W. C. Roberts, and A. S. Fauci. 1982. Atrioventricular valve replacement in the idiopathic hypereosinophilic syndrome. Am. J. Med. 73:77.
6. Harley, J. B., A. S. Fauci, and H. R. Gralnick. 1983. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am. J. Cardiol. 52:321.
7. Gottdiener, J. S., B. J. Maron, R. T. Schooley, J. B. Harley, W. C. Roberts, and A. S. Fauci. 1983. Two-dimensional echocardiographic assessment of the idiopathic hypereosinophilic syndrome: anatomic basis of mitral regurgitation and peripheral embolization. Circulation 67:572.
8. Desreumaux, P., A. Janin, S. Dubucqoui, M.-C. Copin, G. Torpier, A. Capron, M. Capron, and L. Prin. 1993. Synthesis of interleukin-5 by activated eosinophils in patients with eosinophilic heart diseases. Blood 82:1553.
9. Tai, P.-C., C. J. F. Spry, E. G. J. Olsen, S. J. Ackerman, S. Dunnelte, and G. J. Gleich. 1987. Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1:643.
10. de Mello, D. E., H. Liapis, S. Jureidini, S. Nouri, G. M. Kephart, and G. J. Gleich. 1990. Cardiac localization of eosinophil-granule major basic protein in acute necrotizing myocarditis. N. Engl. J. Med. 323:1542.
11. Tai, P-C., D. J. Hayes, J. B. Clark, and C. J. F. Spry. 1982. Toxic effects of human eosinophil secretion products on isolated rat heart cells in vitro. Biochem. J. 204:75.
12. Shah, A. M., D. L. Brutsaert, A. L. Meulemans, L. J. Andries, and M. Capron. 1990. Eosinophils from hypereosinophilic patients damage endocardium of isolated feline heart muscle preparations. Circulation 81:1081.
13. Slungaard, A., and J. R. Mahoney Jr. 1991. Bromide-dependent toxicity of eosinophil peroxidase for endothelium and isolated working rat hearts: a model for eosinophilic endocarditis. J. Exp. Med. 173:117.
14. Shaffer, S. W., E. R. Dimayuga, and S. G. Kayes. 1992. Development and characterization of a model of eosinophil-mediated cardiomyopathy in rats infected with Toxara canis. Am. J. Physiol. 262:H1428.
15. Rohrbach, M. S., C. L. Wheatley, N. R. Slifman, and G. J. Gleich. 1990. Activation of platelets by eosinophil granule proteins. J. Exp. Med. 172:1271.
16. Slungaard, A., G. M. Vercellolti, G. Walker, R. D. Nelson, and H. S. Jacob. 1990. Tumor necrosis factor α/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J. Exp. Med. 171:2025.
17. Slungaard, A., G. M. Vercellotti, T. Tran, G. J. Gleich, and N. S. Key. 1993. Eosinophil cationic granule proteins impair thrombomodulin function. J. Clin. Invest. 91:1721.
18. Gleich, G. J., C. R. Adolphson, and K. M. Leiferman. 1993. The biology of the eosinophilic leukocyte. Annu. Rev. Med. 44:85.
19. Hamann, H. J., R. I. Barker, R. M. Ten, and G. J. Gleich. 1991. The molecular biology of eosinophil granule proteins. Int. Arch. Allergy Appl. Immunol. 94:202.
20. Simionescu, M., and N. Simionescu. 1986. Functions of the endothelial cell surface. Annu. Rev. Physiol. 48:279.
21. Minnicozzi, M., W. N. Duràn, G. J. Gleich, and R. W. Egan. 1994. Eosinophil granule proteins increase microvascular macromolecular transport in the hamster cheek pouch. J. Immunol. 153:2664.
22. Foreman, J. C., and L. M. Lichtenstein. 1980. Induction of histamine secretion by polycations. Biochem. Biophys. Acta 629:587.
23. Raud, J., S. E. Dahlen, G. Smedegard, and P. Hedqvist. 1989. An intravital microscopic model for mast cell-dependent inflammation in the hamster cheek pouch. Acta Physiol. Scand. 135:95.
24. Shier, W. T., D. J. Dubourdieu, and J. P. Durkin. 1984. Polycations as prostaglandin synthesis inducers. Biochim. Biophys. Acta 793:238.
25. Galli, S. J. 1993. New concepts about mast cells. N. Engl. J. Med 328:257.
26. O'Donnel, M. C., S. J. Ackerman, G. J. Gleich, and L. L. Thomas. 1991. Activation of basophils and mast cells histamine release by eosinophil granule major basic protein. J. Exp. Med. 157:1981.
27. Zheutlin, L. M., S. J. Ackerman, G. J. Gleich, and L. L. Thomas. 1984. Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. J. Immunol. 133:2180.
28. Okayama, Y., S. G. El-Lati, K. M. Leiferman, and M. K. Church. 1994. Eosinophil granule proteins inhibit substance P-induced histamine release from human skin mast cells. J. Allergy Clin. Immunol. 93:900.
29. Patella, V., I. Marinò, B. Lamparter, E. Arbustini, M. Adt, and G. Marone. 1995. Human heart mast cells: isolation, purification, ultrastructure, and immunologic characterization. J. Immunol. 154:2855.
30. Patella, V., G. de Crescenzo, A. Ciccarelli, I. Marinò, M. Adt, and G. Marone. 1995. Human heart mast cells: a definitive case of mast cell heterogeneity. Int. Arch. Allergy Immunol. 106:386.
31. Patella, V., V. Casolaro, L. Björck, and G. Marone. 1990. Protein L: a bacterial Ig-binding protein that activates human basophils and mast cells. J. Immunol. 145:3054.
32. Durack, D. T., S. J. Ackerman, D. A. Loegering, and G. J. Gleich. 1981. Purification of human eosinophil-derived neurotoxin. Proc. Natl. Acad. Sci. USA 78:5165.
33. Slifman, N. R., D. A. Loegering, D. J. McKean, and G. J. Gleich. 1986. Ribonuclease activity associated with human eosinophil-derived neurotoxin and eosinophil cationic protein. J. Immunol. 137:2913.
34. Ten, R. M., L. R. Pease, D. J. McKean, M. P. Bell, and G. J. Gleich. 1989. Molecular cloning of the human eosinophil peroxidase: evidence for the existence of a peroxidase multigene family. J. Exp. Med. 169:1757.
35. Gleich, G. J., D. A. Loegering, M. P. Bell, J. L. Checkel, S. J. Ackerman, and D. J. McKean. 1986. Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease. Proc. Natl. Acad. Sci. USA 83:3146.
36. Ackerman, S. J., D. A. Loegering, P. Venge, I. Olsson, J. B. Harley, A. S. Fauci, and G. J. Gleich. 1983. Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. J. Immunol. 131:2977.
37. Gleich, G. J., D. A. Loegering, K. G. Mann, and J. E. Maldonado. 1976. Comparative properties of the Charcot-Leyden crystal protein and the major basic protein from human eosinophils. J. Clin. Invest. 57:633.
38. Patella, V., J.-P. Bouvet, and G. Marone. 1993. Protein Fv produced during viral hepatitis is a novel activator of human basophils and mast cells. J. Immunol. 151:5685.
39. Siraganian, R. P. 1974. An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal. Biochem. 57:383.
40. Patella, V., V. Casolaro, A. Ciccarelli, G. R. Pettit, M. Columbo, and G. Marone. 1995. The antineoplastic bryostatins affect differently human basophils and mast cells. Blood 85:1272.
41. Stellato, C., A. de Paulis, R. Cirillo, P. Mastronardi, B. Mazzarella, and G. Marone. 1991. Heterogeneity of human mast cells and basophils in response to muscle relaxants. Anesthesiology 74:1078.
42. Stellato, C., A. de Paulis, A. Ciccarelli, R. Cirillo, V. Patella, V. Casolaro, and G. Marone. 1992. Anti-inflammatory effect of cyclosporin A on human skin mast cells. J. Invest. Dermatol. 298:800.
43. Lawrence, I. D., J. A. Warner, V. L. Cohan, W. C. Hubbard, A. Kagey-Sobotka, and L. M. Lichtenstein. 1987. Purification and characterization of human skin mast cells: evidence for human mast cell heterogeneity. J. Immunol. 1139:3062.
44. Marone, G., S. Poto, M. Columbo, R. Giugliano, A. Genovese. and M. Condorelli. 1984. Possible role of calmodulin in the control of lysosomal enzyme release from human polymorphonuclear leukocytes. J. Pharmacol. Exp. Ther. 211:678.
45. Snedecor, G. W., and W. G. Cochran. 1980. Statistical Methods. Iowa State University Press, Ames, IA.
46. Irani, A. A., N. M. Schechter, S. S. Craig, G. DeBlois, and L. B. Schwartz. 1986. Two types of human mast cells that have distinct neutral protease composition. Proc. Natl. Acad. Sci. USA 83:4464.
47. Schwartz, L. B., A.-M. A. Irani, K. Roller, M. C. Castells, and N. M. Schechter. 1987. Quantitation of histamine, tryptase, and chymase in dispersed human T and TC mast cells. J. Immunol. 138:2611.
48. Gleich, G. J., E. Frigas, D. A. Loegering, D. L. Wassom, and D. Steinmuller. 1979. Cytotoxic properties of the eosinophil major basic protein. J. Immunol. 123:2925.
49. Gleich, G. J., and C. R. Adolphson. 1986. The eosinophilic leukocyte: structure and function. Adv. Immunol. 39:177.
50. Hastie, A. T., D. A. Loegering, G. J. Gleich, and F. Kueppers. 1987. The effect of purified human eosinophil major basic protein on mammalian ciliary activity. Am. Rev. Respir. Dis. 135:848.
51. Jakoby, D. B., I. F. Ueki, J. H. Widdicombe, D. A. Loegering, and G. J. Gleich. 1988. Effect of human eosinophil major basic protein on ion transport in dog tracheal epithelium. Am. Rev. Respir. Dis. 137:13.
52. Marone, G., R. Petracca, S. Vigorita, and V. Casolaro. 1990. Adenosine receptors of human leukocytes. II. Characterization of an inhibitory P-site. Biochem. Pharmacol. 401963.
53. Wasmoen, T. L., M. P. Bell, D. A. Loegering, G. J. Gleich, F. G. Prendergast, and D. J. McKean. 1988. Biochemical and amino acid sequence analysis of human eosinophil granule major basic protein. J. Biol. Chem. 263:12559.
54. MacDonald, S. M., R. P. Schleimer, A. Kagey-Sobotka, S. Gillis, L. M. Lichtenstein. 1989. Recombinant IL-3 induces histamine release from human basophils. J. Immunol. 142:3527.
55. Columbo, M., V. Casolaro, J. A. Warner, D. W. MacGlashan, Jr., A. Kagey-Sobotka, and L. M. Lichtenstein. 1990. The mechanism of mediator release from human basophils induced by platelet-activating factor. J. Immunol. 145:3855.
56. Thomas, L. L., M. D. Haskell, E. U. Sarmiento, and Y. Bilimoria. 1994. Distinguishing features of basophil and neutrophil activation by major basic protein. J. Allergy Clin. Immunol. 94:1171.
57. 1 receptor on coronary hemodynamics in man. Circulation 73:1175.
58. Graver, L. M., D. A. Robertson, R. Levi, C. G. Becker, B. B. Weksler, and W. A. Gay. 1986. IgE-mediated hypersensitivity in human heart tissue: histamine release and functional changes. J. Allergy Clin. Immunol. 77:709.
59. Marone, G., A. Giordano, R. Cirillo, M. Triggiani, and C. Vigorito. 1988. Cardiovascular and metabolic effects of peptide leukotrienes in man. Am. NY Acad. Sci. 524:321.
60. Marone, G., G. de Crescendo, M. Adt, V. Patella, E. Arbustini, and A. Genovese. 1995. Immunological characterization and functional importance of human heart mast cells. Immunopharmacology 31:1.
61. Bankl, H. C., T. Radaszkiewicz, G. W. Klappacher, D. Glogar, W. R. Sperr, K. GroBschmidt, H. Bankl, K. Lechner, and P. Valent. 1995. Increase and redistribution of cardiac mast cells in auricular thrombosis: possible role of kit ligand. Circulation 91:275.
62. Kaartinen, M., A. Penttilä, and P. T. Kovanen. 1994. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation 90:1669.
63. Schwartz, L. B., M. S. Kawahara, T. E. Hugli, D. Vik, D. T. Fearon, and K. F. Austen. 1983. Generation of C3a anaphylatoxin from human C3 by human mast cell tryptase. J. Immunol. 130:1891.
64. Assem, E. S. K. 1994. Release of eosinophil cationic protein (ECP) in anaphylactoid anaesthetic reactions in vivo and in vitro. Agents Actions 41 (Spec. Conf. Issue): C11.
65. Niggemann, B., K. Beyer, and U. Wahn. 1994. The role of eosinophils and eosinophil cationic protein in monitoring oral challenge tests in children with food-sensitive atopic dermatitis. J. Allergy Clin. Immunol. 94:963.
66. Gleich, G. J. 1990. The eosinophil and bronchial asthma current understanding. J. Allergy Clin. Immunol. 85:422.
67. Smith, P. L., A. Kagey-Sobotka, E. R. Bleecker, R. Traystman, A. P. Kaplan, H. Gralnick, M. D. Valentine, S. Permutt, and L. M. Lichtenstein. 1980. Physiologic manifestations of human anaphylaxis. J. Clin. Invest. 66:1072.